peptobiotics tech

peptobiotics techpeptobiotics techpeptobiotics tech

peptobiotics tech

peptobiotics techpeptobiotics techpeptobiotics tech
  • Home
  • Solution
  • Mission
  • Careers
  • Contact Us
  • More
    • Home
    • Solution
    • Mission
    • Careers
    • Contact Us
  • Home
  • Solution
  • Mission
  • Careers
  • Contact Us

World first synthetic biology alternative to livestock antibiotics

World first synthetic biology alternative to livestock antibioticsWorld first synthetic biology alternative to livestock antibioticsWorld first synthetic biology alternative to livestock antibiotics

World first synthetic biology alternative to livestock antibiotics

World first synthetic biology alternative to livestock antibioticsWorld first synthetic biology alternative to livestock antibioticsWorld first synthetic biology alternative to livestock antibiotics

Expanding into the United States Market

Expanding into the United States represents a significant opportunity for Peptobiotics Tech, which has established a strong presence in Singapore. As we embark on this strategic expansion, several key factors will shape our approach and ensure our success in this dynamic and competitive market.

Building Strategic Partnerships

The United States is one of the largest market in the world, valued at over $180 billion and projected to grow annually. This dramatic growth is fueled by an aging population, technological advancements, and an increasing demand for innovative healthcare solutions. 

Conclusion

In conclusion, expanding into the United States from Singapore is an exciting and strategic move for Peptobiotics. By focusing on regulatory compliance, building strategic partnerships, understanding cultural differences, and investing in targeted marketing efforts, we can establish a strong foothold in one of the world’s largest markets. 

The future of feed additives is synthetic biology

We make agriculture more productive, humane and sustainable by promoting  growth and protecting against pathogens using a new type of antibiotic  alternative that does not cause resistance.

Our recombinant peptides are synthetic biology products manufactured in a  patent pending precision fermentation process. We are launching a range  of products across livestock and aquaculture in Asia.

Innovating with nature

By leveraging advances in human medicine and synthetic biology, we are  creating a new class of feed additives that can maximise animal welfare,  gut health, feed conversion and growth with comparable performance to  antibiotics – but without creating drug resistant superbugs.

Tailored solutions

Encompassing software, high-throughput screening and rational design,  our pipeline allows us to create customised peptides for use in a  variety of livestock targets and applications.

Our Technology

We employ our discovery pipeline to engineer custom recombinant peptides  to replace animal antibiotics. Our patent pending production process  makes peptide solutions cost competitive with conventional antibiotics.  Our unique peptide sequences are engineered for efficacy, safety and  scalability.

Subscribe to our newsletter

Interested in buying our products, investing or collaborating? We send out monthly updates on our progress towards an antibiotic free agricultural system.

Copyright © 2024

All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept